Does ELACESTRANT Cause Neoplasm progression? 76 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Neoplasm progression have been filed in association with ELACESTRANT (ORSERDU). This represents 1.1% of all adverse event reports for ELACESTRANT.
76
Reports of Neoplasm progression with ELACESTRANT
1.1%
of all ELACESTRANT reports
2
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm progression From ELACESTRANT?
Of the 76 reports, 2 (2.6%) resulted in death, 11 (14.5%) required hospitalization, and 1 (1.3%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELACESTRANT. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does ELACESTRANT Cause?
Nausea (1,454)
Fatigue (1,081)
Disease progression (777)
Vomiting (662)
Diarrhoea (540)
Death (499)
Drug ineffective (478)
Constipation (389)
Product dose omission issue (364)
Decreased appetite (363)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which ELACESTRANT Alternatives Have Lower Neoplasm progression Risk?
ELACESTRANT vs ELAFIBRANOR
ELACESTRANT vs ELAGOLIX
ELACESTRANT vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
ELACESTRANT vs ELAPEGADEMASE-LVLR
ELACESTRANT vs ELASOMERAN